Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for angiotensin root_references_citation in Reference Text / Citation (approximate match)

Showing 951 - 960 of 1355 results

First page
Previous page
Next page
Next page

AUTOLOGOUS ADIPOSE DERIVED MESENCHYMAL STEM CELLS (MSCS)

KA0IJR9DZ7

Status:

Possibly Marketed Outside US

Source:

NCT04675359: Phase 4 Interventional Unknown status Knee Osteoarthritis

(2021)

Source URL:

https://clinicaltrials.gov/ct2/show/NCT04675359

Class:

STRUCTURALLY DIVERSE

PROSOLV ODT

7ASB3EQN9N

Status:

Excipient

Source:

Source URL:

https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=P

Class:

G1 SPECIFIED SUBSTANCE

Silicified Microcrystalline Cellulose (65 µm)

K2EZE348C4

Status:

Excipient

Source:

Source URL:

https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=S

Class:

G1 SPECIFIED SUBSTANCE

OPADRY II Y-30-18037 WHITE

RX96DK7VVX

Status:

Excipient

Source:

26mg ORAL TABLET, FILM COATED, EXTENDED RELEASE

Source URL:

https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O

Class:

G1 SPECIFIED SUBSTANCE

OPADRY II RED 85G94101

A2E86PPP6D

Status:

Excipient

Source:

Source URL:

https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O

Class:

G1 SPECIFIED SUBSTANCE

OPADRY II Y-22-7719 WHITE

B38S8YKT74

Status:

Excipient

Source:

Source URL:

https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O

Class:

G1 SPECIFIED SUBSTANCE

OPADRY II 85F18422 WHITE

UM45RMS9QT

Status:

Excipient

Source:

Source URL:

https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O

Class:

G1 SPECIFIED SUBSTANCE

OPADRY YS-1-19025-A CLEAR

4PQ7L4V6AQ

Status:

Excipient

Source:

Source URL:

https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O

Class:

G1 SPECIFIED SUBSTANCE

OPADRY II 85F18378 WHITE

VTB5DCJ7N6

Status:

Excipient

Source:

Source URL:

https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O

Class:

G1 SPECIFIED SUBSTANCE

OPADRY II 33G11938 GREEN

B53ZH89YAO

Status:

Excipient

Source:

Source URL:

https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm?event=browseByLetter.page&Letter=O

Class:

G1 SPECIFIED SUBSTANCE

Structurally Diverse

AUTOLOGOUS ADIPOSE DERIVED MESENCHYMAL STEM CELLS (MSCS)

Concept

PROSOLV ODT

Concept

Silicified Microcrystalline Cellulose (65 µm)

RX96DK7VVX
Not a public record

Concept

OPADRY II Y-30-18037 WHITE

A2E86PPP6D
Not a public record

Concept

OPADRY II RED 85G94101

B38S8YKT74
Not a public record

Concept

OPADRY II Y-22-7719 WHITE

UM45RMS9QT
Not a public record

Concept

OPADRY II 85F18422 WHITE

4PQ7L4V6AQ
Not a public record

Concept

OPADRY YS-1-19025-A CLEAR

VTB5DCJ7N6
Not a public record

Concept

OPADRY II 85F18378 WHITE

Concept

OPADRY II 33G11938 GREEN

Showing 951 - 960 of 1355 results

First page
Previous page
Next page
Next page

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1